Status:
COMPLETED
Medication Adherence in Rheumatic Diseases
Lead Sponsor:
Duke University
Conditions:
Chronic Rheumatic Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators will pilot test a clinician-led intervention to improve medication adherence in general rheumatology clinic across a spectrum of rheumatic diseases. The study will assess feasibility...
Eligibility Criteria
Inclusion
- all providers at Southpoint Rheumatology All patients with a rheumatic disease diagnosis currently prescribed at least one rheumatic medication will be included in the analysis
Exclusion
- new patients, those who are not prescribed any rheumatic disease medications, or do not have available pharmacy refill data
Key Trial Info
Start Date :
February 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 22 2024
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT06018350
Start Date
February 2 2024
End Date
June 22 2024
Last Update
September 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University
Durham, North Carolina, United States, 27710